Bai Song Mei
Fortune : 5 M $ au 30/09/2026
Fortune : 5 M $ au 30/09/2026
Dr. Bai Song Mei is a Chief Medical Officer at City Therapeutics, Inc. Dr. Mei was previously employed as a Chief Medical Officer & Executive Vice President by Editas Medicine, Inc. and a Senior Global Project Head-Rare Disease by Sanofi.
He received his doctorate degree from the University of Toledo (Ohio).
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,44% | 15/10/2026 | 228 743 ( 0,44% ) | 5 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 31/12/2024 |
| SANOFI | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Toledo (Ohio)
University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Bengbu Medical College
Bengbu Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuhan University School of Law
Wuhan University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national